NASDAQ: PRTO       Proteon Thera Com ST
Last Price Today's Change   Day's Range   Trading Volume
0.294   +0.014 (5.00%)  0.275 - 0.30  143,000


Avg Volume (4 weeks):160,636
4 Weeks Range:0.221 - 0.34
4 Weeks Price Volatility (%):
52 Weeks Range:0.22 - 3.94
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Proteon Therapeutics Inc. is an early-stage biopharmaceutical company engaged in the development of elastases to treat the growing medical needs of renal and vascular disease patients. The Company's product candidate, vonapanitase, is a recombinant human elastase, developing to reduce vascular access failure in patients with chronic kidney disease undergoing or preparing for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. It competes with companies developing vascular access technologies, including BioConnect Systems, Caymus Medical, Phraxis, CreatiVasc, and TVA Medical, among others.

  Be the first to like this.


4706  3347  638  230 

Top 10 Active Counters
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers